NasdaqCM - Nasdaq Real Time Price
USD
BriaCell Therapeutics Corp. (BCTX)
3.7700
+0.0750
(+2.06%)
As of 10:07:44 AM EST. Market Open.
Loading chart for BCTX
- Previous Close
3.6950 - Open
3.7300 - Bid 3.4400 x 100
- Ask 3.7100 x 100
- Day's Range
3.7200 - 3.7700 - 52 Week Range
2.6000 - 13.0900 - Volume
3,672 - Avg. Volume
259,737 - Market Cap (intraday)
32.921M - Beta (5Y Monthly) 1.66
- PE Ratio (TTM)
-- - EPS (TTM)
-6.9700 - Earnings Date (est.) --
- Forward Dividend & Yield -- (0.00%)
- 1y Target Est
-- - Moby Rating Neutral
Recent News
View MorePerformance Overview
Trailing total returns as of 11/10/2026, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .
YTD Return
BCTX
50.99%
S&P/TSX Composite index (^GSPTSE)
13.97%
1-Year Return
BCTX
67.11%
S&P/TSX Composite index (^GSPTSE)
21.42%
3-Year Return
BCTX
90.63%
S&P/TSX Composite index (^GSPTSE)
85.42%
5-Year Return
BCTX
96.17%
S&P/TSX Composite index (^GSPTSE)
68.18%
Earnings Trends
View MoreStatistics
View MoreValuation Measures
-
Market Cap
-
Enterprise Value
-
Trailing P/E
-
Forward P/E
-
PEG Ratio (current)
-
Price/Sales (ttm)
-
Price/Book (mrq)
-
Enterprise Value/Revenue
-
Enterprise Value/EBITDA
Financial Highlights
Profitability and Income Statement
-
Profit Margin
0.00%
-
Return on Assets (ttm)
-99.64%
-
Return on Equity (ttm)
-214.79%
-
Revenue (ttm)
--
-
Net Income Avi to Common (ttm)
-34.9M
-
Diluted EPS (ttm)
-6.9700
Balance Sheet and Cash Flow
-
Total Cash (mrq)
20.54M
-
Total Debt/Equity (mrq)
--
-
Levered Free Cash Flow (ttm)
-16.27M
